{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T20:59:44Z","timestamp":1782421184926,"version":"3.54.5"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.ejogrb.2025.114042","type":"journal-article","created":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T11:03:34Z","timestamp":1746875014000},"page":"114042","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Multimodal management of peritoneal sarcomatosis in uterine sarcoma: Long term outcomes from a single institute in India"],"prefix":"10.1016","volume":"311","author":[{"given":"M D","family":"Ray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohan","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhil","family":"BN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ejogrb.2025.114042_b0005","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.ejso.2021.10.013","article-title":"Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in peritoneal sarcomatosis-A systematic review and meta-analysis","volume":"48","author":"Wong","year":"2022","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejogrb.2025.114042_b0010","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1046\/j.1365-2168.2002.02274.x","article-title":"Peritoneal carcinomatosis from colorectal cancer","volume":"89","author":"Jayne","year":"2002","journal-title":"Br J Surg"},{"issue":"3","key":"10.1016\/j.ejogrb.2025.114042_b0015","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1200\/JCO.2011.37.1039","article-title":"Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of North Central Cancer Treatment Group phase III trials N9741 and N9841","volume":"30","author":"Franko","year":"2012","journal-title":"J Clin Oncol Jan 20"},{"issue":"7","key":"10.1016\/j.ejogrb.2025.114042_b0020","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.ejso.2012.03.008","article-title":"Outcomes of colorectal cancer patients with peritoneal carcinomatosis treated with chemotherapy with and without targeted therapy","volume":"38","author":"Klaver","year":"2012","journal-title":"Eur J Surg Oncol"},{"issue":"20","key":"10.1016\/j.ejogrb.2025.114042_b0025","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1200\/JCO.2011.39.7166","article-title":"Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"30","author":"Chua","year":"2012","journal-title":"J Clin Oncol"},{"issue":"36","key":"10.1016\/j.ejogrb.2025.114042_b0030","doi-asserted-by":"crossref","first-page":"6237","DOI":"10.1200\/JCO.2009.23.9640","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience","volume":"27","author":"Yan","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejogrb.2025.114042_b0035","unstructured":"Cancer Facts and Figures 201Atlanta, GA: American Cancer Society. Available at: https:\/\/www.cancer.org\/research\/cancer-facts- statistics\/all-cancer-facts-figures\/cancer-facts-figures-2017.html."},{"key":"10.1016\/j.ejogrb.2025.114042_b0040","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ejogrb.2023.06.016","article-title":"Uterine sarcomas: A critical review of the literature","volume":"287","author":"Giannini","year":"2023","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ejogrb.2025.114042_b0045","doi-asserted-by":"crossref","unstructured":"Munene G, Mack LA, Temple WJ. Systematic Review on the Efficacy of Multimodal Treatment of Sarcomatosis with Cytoreduction and Intraperitoneal Chemotherapy. Ann Surg Oncol [Internet]. 2011 Jan 1 [cited 2025 Feb 28];18(1):207\u201313. Available from: https:\/\/doi.org\/10.1245\/s10434-010-1229-3.","DOI":"10.1245\/s10434-010-1229-3"},{"key":"10.1016\/j.ejogrb.2025.114042_b0050","doi-asserted-by":"crossref","unstructured":"Sugarbaker PH. Long-term survival is possible using cytoreductive surgery plus HIPEC for sarcomatosis\u2014Case report of 2 patients. Int J Surgery Case Reports [Internet]. 2019 Jan 1 [cited 2025 Mar 17];64:10\u20134. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2210261219305085.","DOI":"10.1016\/j.ijscr.2019.09.009"},{"issue":"4","key":"10.1016\/j.ejogrb.2025.114042_b0055","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1245\/s10434-023-14786-5","article-title":"Cytoreductive surgery with bidirectional intraoperative chemotherapy (BDIC) using intravenous ifosfamide plus hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal sarcomatosis: A retrospective cohort study","volume":"31","author":"Almasri","year":"2024","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.ejogrb.2025.114042_b0060","doi-asserted-by":"crossref","first-page":"694","DOI":"10.3109\/0284186X.2012.689111","article-title":"Diagnosis and treatment of sarcoma of the uterus","volume":"51","author":"Trop\u00e9","year":"2012","journal-title":"A reviewActa Oncol"},{"issue":"12","key":"10.1016\/j.ejogrb.2025.114042_b0065","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/S1470-2045(09)70226-8","article-title":"Clinical management of uterine sarcomas","volume":"10","author":"Amant","year":"2009","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.ejogrb.2025.114042_b0070","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.ygyno.2021.09.010","article-title":"Phase 2 study of anastrozole in rare cohorts of patients with estrogen receptor\/progesterone receptor positive leiomyosarcomas and carcinosarcomas of the uterine corpus: The PARAGON trial (ANZGOG 0903)","volume":"163","author":"Edmondson","year":"2021","journal-title":"Gynecol Oncol"},{"issue":"8","key":"10.1016\/j.ejogrb.2025.114042_b0075","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.ciresp.2024.05.006","article-title":"Radical cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal sarcomatosis: Results from a reference center and considerations based on current evidence","volume":"102","author":"Mu\u00f1oz Casares","year":"2024","journal-title":"Cir Esp (Engl Ed)"},{"key":"10.1016\/j.ejogrb.2025.114042_b0080","doi-asserted-by":"crossref","unstructured":"Baratti D, Pennacchioli E, Kusamura S, Fiore M, Balestra MR, Colombo C, et al. Peritoneal Sarcomatosis: Is There a Subset of Patients Who May Benefit from Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy? Ann Surg Oncol [Internet]. 2010 Dec 1 [cited 2025 Feb 28];17(12):3220\u20138. Available from: https:\/\/doi.org\/10.1245\/s10434-010-1178-x.","DOI":"10.1245\/s10434-010-1178-x"},{"key":"10.1016\/j.ejogrb.2025.114042_b0085","doi-asserted-by":"crossref","unstructured":"Bonvalot S, Cavalcanti A, Le P\u00e9choux C, Terrier P, Vanel D, Blay JY, et al. Randomized trial of cytoreduction followed by intraperitoneal chemotherapy versus cytoreduction alone in patients with peritoneal sarcomatosis. European Journal of Surgical Oncology (EJSO) [Internet]. 2005 Oct [cited 2025 Feb 28];31(8):917\u201323. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798305001356.","DOI":"10.1016\/j.ejso.2005.04.010"},{"key":"10.1016\/j.ejogrb.2025.114042_b0090","doi-asserted-by":"crossref","unstructured":"Naffouje SA, Tulla KA, Salti GI. A Simplified Peritoneal Sarcomatosis Score for patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Gastrointest Oncol [Internet]. 2018 Dec [cited 2025 Mar 18];9(6):1138\u201343. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6286947\/.","DOI":"10.21037\/jgo.2018.08.19"},{"issue":"4","key":"10.1016\/j.ejogrb.2025.114042_b0095","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.3390\/cancers15041340","article-title":"Treatment pathways and prognosis in advanced sarcoma with peritoneal sarcomatosis","volume":"15","author":"Klingler","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ejogrb.2025.114042_b0100","unstructured":"Rahaman J, Cohen CJ. Patterns of Spread. In: Holland-Frei Cancer Medicine 6th edition [Internet]. BC Decker; 2003 [cited 2025 Mar 18]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK12378\/."},{"key":"10.1016\/j.ejogrb.2025.114042_b0105","doi-asserted-by":"crossref","unstructured":"Sardi A, Sipok A, Baratti D, Deraco M, Sugarbaker P, Salti G, et al. Multi-institutional study of peritoneal sarcomatosis from uterine sarcoma treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. European Journal of Surgical Oncology [Internet]. 2017 Nov [cited 2025 Feb 28];43(11):2170\u20137. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798317306509.","DOI":"10.1016\/j.ejso.2017.08.011"},{"key":"10.1016\/j.ejogrb.2025.114042_b0110","doi-asserted-by":"crossref","unstructured":"Munoz-Zuluaga CA, King MC, Ledakis P, Gushchin V, Sittig M, Nieroda C, et al. Systemic chemotherapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS\/HIPEC) in patients with high-grade mucinous carcinoma peritonei of appendiceal origin. European Journal of Surgical Oncology [Internet]. 2019 Sep 1 [cited 2025 Mar 18];45(9):1598\u2013606. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0748798319304469.","DOI":"10.1016\/j.ejso.2019.05.008"},{"key":"10.1016\/j.ejogrb.2025.114042_b0115","doi-asserted-by":"crossref","unstructured":"Tavani A, Soler M, Vecchia CL, Negri E, Gallus S, Franceschi S. Body weight and risk of soft-tissue sarcoma. Br J Cancer [Internet]. 1999 Nov [cited 2025 Mar 18];81(5):890\u20132. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC2374286\/.","DOI":"10.1038\/sj.bjc.6690781"},{"key":"10.1016\/j.ejogrb.2025.114042_b0120","doi-asserted-by":"crossref","unstructured":"Ioffe YJ, Li AJ, Walsh CS, Karlan BY, Leuchter R, Forscher C, et al. Hormone receptor expression in uterine sarcomas: Prognostic and therapeutic roles. Gynecologic Oncology [Internet]. 2009 Dec 1 [cited 2025 Mar 18];115(3):466\u201371. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0090825809006398.","DOI":"10.1016\/j.ygyno.2009.08.014"},{"key":"10.1016\/j.ejogrb.2025.114042_b0125","doi-asserted-by":"crossref","unstructured":"Karamveri C, Pallas N, Kyziridis D, Hristakis C, Kyriakopoulos V, Kalakonas A, et al. Cytoreductive Surgery in Combination with HIPEC in the Treatment of Peritoneal Sarcomatosis. Indian J Surg Oncol [Internet]. 2019 Mar [cited 2025 Mar 18];10(1):40\u20135. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6414567\/.","DOI":"10.1007\/s13193-018-0782-2"},{"key":"10.1016\/j.ejogrb.2025.114042_b0130","doi-asserted-by":"crossref","unstructured":"Mehta SS, Gelli M, Agarwal D, Go\u00e9r\u00e9 D. Complications of Cytoreductive Surgery and HIPEC in the Treatment of Peritoneal Metastases. Indian J Surg Oncol [Internet]. 2016 Jun [cited 2025 Mar 18];7(2):225\u20139. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4818615\/.","DOI":"10.1007\/s13193-016-0504-6"},{"key":"10.1016\/j.ejogrb.2025.114042_b0135","doi-asserted-by":"crossref","unstructured":"Wong LCK, Li Z, Fan Q, Tan JWS, Tan QX, Wong JSM, et al. Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in peritoneal sarcomatosis\u2014A systematic review and meta-analysis. European Journal of Surgical Oncology [Internet]. 2022 Mar 1 [cited 2025 Mar 18];48(3):640\u20138. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0748798321007617.","DOI":"10.1016\/j.ejso.2021.10.013"},{"key":"10.1016\/j.ejogrb.2025.114042_b0140","doi-asserted-by":"crossref","unstructured":"Klingler F, Ashmawy H, H\u00e4berle L, Esposito I, Schimm\u00f6ller L, Knoefel WT, et al. Treatment Pathways and Prognosis in Advanced Sarcoma with Peritoneal Sarcomatosis. Cancers (Basel) [Internet]. 2023 Feb 20 [cited 2025 Mar 18];15(4):1340. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC9954769.","DOI":"10.3390\/cancers15041340"},{"key":"10.1016\/j.ejogrb.2025.114042_b0145","doi-asserted-by":"crossref","unstructured":"Paik ES, Kang JH, Kim J, Lee YJ, Choi CH, Kim TJ, et al. Prognostic factors for recurrence and survival in uterine leiomyosarcoma: Korean single center experience with 50 cases. Obstet Gynecol Sci [Internet]. 2019 Mar [cited 2025 Mar 18];62(2):103\u201311. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6422845\/.","DOI":"10.5468\/ogs.2019.62.2.103"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211525003185?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211525003185?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T03:47:48Z","timestamp":1774928868000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211525003185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":29,"alternative-id":["S0301211525003185"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2025.114042","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multimodal management of peritoneal sarcomatosis in uterine sarcoma: Long term outcomes from a single institute in India","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2025.114042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114042"}}